pathology microbiology and immunology Archives
Terker selected as VUMC Discovery Scholar in Health and Medicine
Oct. 27, 2022— by Bill Snyder Andrew Terker, MD, PhD, assistant professor of Medicine in the Division of Nephrology and Hypertension at Vanderbilt University Medical Center, has been selected as the 2022 VUMC Discovery Scholar in Health and Medicine. The Discovery Scholars program was launched in 2020 with funding from the Brock Family Directorship in Career Development...
VUMC lands grant to build top-line biosafety facility
Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
Vinson named Senior Vice President for Diagnostic Laboratory Services
Sep. 29, 2022—David Vinson has been named Senior Vice President for Diagnostic Laboratory Services at Vanderbilt University Medical Center.
MEGAMicrobe event shows children that science can be fun
Sep. 22, 2022—More than 100 children who attended the “MEGAMicrobe Express” community science fair on Sept. 17 at the Warner Elementary Arts Magnet School in East Nashville.
Study identifies key player in T cell “education”
Sep. 1, 2022—New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output.
Monkeypox testing available for eligible VUMC patients
Aug. 31, 2022—Vanderbilt University Medical Center is now offering in-house monkeypox polymerase chain reaction (PCR) diagnostic testing for patients who are eligible.
Vanderbilt researchers discover how gut inflammation leads to bone loss
Aug. 25, 2022—Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of “bone-eating” cells, leading to bone loss.
Study describes how E. coli co-opts cells, causes recurrent UTIs
Aug. 25, 2022—Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.
Rise seen in parechovirus cases among children
Aug. 11, 2022—Doctors at Vanderbilt are seeing an unusually high number of young patients infected with a virus called parechovirus.
C. difficile may contribute to colorectal cancer: study
Jul. 28, 2022—A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.
Grad student Shelton selected as Vanderbilt Prize Student Scholar
Jul. 13, 2022—Catherine Shelton has been selected as the 2022 Vanderbilt Prize Student Scholar.
Mathers Foundation award supports study of crosstalk between skeletal, immune systems
Jul. 7, 2022—Vanderbilt's Jim Cassat, MD, PhD, has received a three-year, $750,000 award from the G. Harold and Leila Y. Mathers Foundation to support research exploring the interplay between bone homeostasis and infectious disease.